Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

575
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
575
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

688
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
688
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.2K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.8K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

977
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
977

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cellular Immunological Memory T Cells and <i>IL15RA</i> Gene Polymorphism in COVID-19 Vaccinated Individuals from Southern Brazil.

Diagnostics (Basel, Switzerland)·2026
Same author

Ganciclovir Resistance-Linked Mutations in the HCMV <i>UL97</i> Gene: Sanger Sequencing Analysis in Samples from Transplant Recipients at a Tertiary Hospital in Southern Brazil.

Diagnostics (Basel, Switzerland)·2025
Same author

Integrated molecular profiling of <i>RAS</i>, <i>BRAF</i> mutations, and mismatch repair status in advanced colorectal carcinoma: insights from gender and tumor laterality.

Journal of gastrointestinal oncology·2024
Same author

SARS-CoV-2 Variants of Concern: Presumptive Identification via Sanger Sequencing Analysis of the Receptor Binding Domain (RBD) Region of the <i>S</i> Gene.

Diagnostics (Basel, Switzerland)·2023
Same author

RT-qPCR half-reaction optimization for the detection of SARS-CoV-2.

Revista da Sociedade Brasileira de Medicina Tropical·2021
Same author

SARS-CoV-2 nucleic acid shedding is variable for every person.

Revista da Sociedade Brasileira de Medicina Tropical·2021
Same journal

Five-Year Risk of CIN3+ After CIN1 Biopsy in a Norwegian Screening Setting: Comparison of CIN1 Diagnosed in a Single Calendar Year and in Two Consecutive Calendar Years.

Pathogens (Basel, Switzerland)·2026
Same journal

Ventilator-Associated Pneumonia (VAP) Prevention Bundle: A Multicenter Cross-Sectional Saudi Study to Assess Knowledge, Adherence, and Perceived Barriers Among ICU Practitioners in Hail Region.

Pathogens (Basel, Switzerland)·2026
Same journal

Anti-<i>Borrelia</i> IgG Seropositivity Among Hemodialysis Patients with Chronic Kidney Disease of Unknown Etiology: A Preliminary Case-Control Study from Northern Türkiye.

Pathogens (Basel, Switzerland)·2026
Same journal

Molecular Characterization of Hemotropic <i>Mycoplasma</i> spp. From Bats (Chiroptera) in the Northern Pantanal, Brazil.

Pathogens (Basel, Switzerland)·2026
Same journal

Characterization of Durum-Einkorn Amphiploids for Introgression of Powdery Mildew Resistance from Einkorn into Common Wheat.

Pathogens (Basel, Switzerland)·2026
Same journal

Human Orthohantavirus Infections: A Narrative Review.

Pathogens (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: Feb 28, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.3K

Tuberculosis Diagnostic Methods: Clinical Applicability, Implementation Challenges, and Integrated Testing

Eduarda Rabello1, Fernanda de-Paris2

  • 1Specialization in Clinical Microbiology, Institute of Basic Health Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre 90035-903, RS, Brazil.

Pathogens (Basel, Switzerland)
|February 27, 2026
PubMed
Summary
This summary is machine-generated.

Tuberculosis diagnosis faces challenges due to varied lab methods, HIV, and drug resistance. This review examines diagnostic tools from implementation and real-world constraints to improve global TB strategies.

Keywords:
diagnosisdiagnostic testssensitivityspecificitytuberculosis

More Related Videos

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

82.1K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.2K

Related Experiment Videos

Last Updated: Feb 28, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.3K
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

82.1K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.2K

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Tuberculosis (TB) is a leading infectious cause of death globally, worsened by HIV and drug resistance.
  • Existing diagnostic methods for TB vary in applicability and impact across different healthcare settings.
  • There's a need for practical, implementation-focused reviews of TB diagnostics.

Purpose of the Study:

  • To provide a comprehensive overview of laboratory diagnostic methods for active and latent TB.
  • To emphasize clinical applicability, implementation challenges, and integration within diagnostic strategies.
  • To adopt an implementation-oriented perspective, considering real-world constraints and regional disparities.

Main Methods:

  • Review of conventional methods (smear microscopy, culture) and modern technologies (NAATs, LAMP, LPAs, NGS, lateral flow assays).
  • Critical examination of diagnostic methods based on real-world constraints, regional disparities, and evidence gaps.
  • Integration of WHO guidance with contextual and operational considerations.

Main Results:

  • Strengths and limitations of various TB diagnostic methods are highlighted in different contexts.
  • Implementation challenges including infrastructure, biosafety, workforce, and sustainability are discussed.
  • Under-addressed areas like latent TB and co-pathogen investigation are considered.

Conclusions:

  • Rational test selection and integrated diagnostic workflows are crucial for strengthening TB strategies.
  • Tailoring diagnostic approaches to local health system capacity and patient populations is essential for effectiveness and equity.
  • This review supports informed decision-making for TB diagnostic implementation worldwide.